Iraes

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-12-20
Clinical Trial Update: Thymosin Alpha-1 for irAE Secondary to ICIs [Phase 4]
A Phase 4 clinical trial update for Thymosin Alpha-1 addressing immune-related adverse events (irAEs) associated with immune checkpoint inhi…